Cipla is currently trading at Rs. 371.55, up by 4.65 points or 1.27% from its previous closing of Rs. 366.90 on the BSE.
The scrip opened at Rs. 366.90 and has touched a high and low of Rs. 371.80 and Rs. 365.05 respectively. So far 91,000 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 371.80 on 27-Aug-2012 and a 52 week low of Rs. 273.60 on 06-Sep-2011.
Last one week high and low of the scrip stood at Rs. 371.80 and Rs. 355.85 respectively. The current market cap of the company is Rs. 29,832 crore.
The promoters holding in the company stood at 36.80% while Institutions and Non-Institutions held 34.23% and 28.73% respectively.
Life Insurance Corporation (LIC) of India has offloaded 3.87 percent stake in pharma major, Cipla for Rs 1,125 crore. The company has sold 31.06 million shares between September 18, 2008 and August 21, 2012 at an average price of Rs 362.16 a share.
Following the sale, LIC’s stake in the Mumbai-based drug maker has declined to 8.34 percent from 12.21 percent.
Cipla focuses on development of new formulations and has a wide range of pharmaceutical products. It offers prescription drugs, bulk drugs, animal products and pesticides. It also offers a wide range of food and beverages, baked foods, oral hygiene products, detergents, room fresheners and personal care products.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1464.85 |
Dr. Reddys Lab | 5955.65 |
Cipla | 1477.15 |
Zydus Lifesciences | 1050.35 |
Lupin | 1603.55 |
View more.. |